carmustine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 12 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Allogeneic stem cell transplant (SCT) after high-dose conditioning with BEAM/fludarabine/total body irradiation (TBI) in patients with relapsed or refractory lymphoma has shown promising results in a pilot study." | 9.17 | Allogeneic stem cell transplantation for relapsed or refractory lymphoma after conditioning with BEAM/fludarabine/TBI. ( Bucher, C; Buser, A; Gerull, S; Halter, J; Heim, D; O'Meara, A; Passweg, J; Stern, M, 2013) |
| "Allogeneic stem cell transplant (SCT) after high-dose conditioning with BEAM/fludarabine/total body irradiation (TBI) in patients with relapsed or refractory lymphoma has shown promising results in a pilot study." | 5.17 | Allogeneic stem cell transplantation for relapsed or refractory lymphoma after conditioning with BEAM/fludarabine/TBI. ( Bucher, C; Buser, A; Gerull, S; Halter, J; Heim, D; O'Meara, A; Passweg, J; Stern, M, 2013) |
| " In an attempt to reduce the high procedure-related mortality reported with allografting in lymphoma, we have used BEAM (BCNU, etoposide, cytarabine and melphalan), a standard conditioning regimen for autologous transplantation." | 3.70 | Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity. ( Byrne, JL; Carter, GI; Cull, GM; Hale, G; Haynes, AP; Miflin, G; Rebello, P; Russell, NH; Waldmann, H, 2000) |
| "Of 79 evaluable patients, 58 (73%) had follicular lymphoma, 13 (16%) mantle cell lymphoma and 8 (10%) lymphoplasmacytic lymphoma." | 2.73 | Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group. ( Dörken, B; Dreyling, M; Forstpointner, R; Freund, M; Ganser, A; Hiddemann, W; Hoster, E; Huber, C; Ludwig, WD; Nickenig, C; Trümper, L; Unterhalt, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Meara, A | 1 |
| Halter, J | 1 |
| Heim, D | 1 |
| Gerull, S | 1 |
| Bucher, C | 1 |
| Passweg, J | 1 |
| Buser, A | 1 |
| Stern, M | 1 |
| Milojković, D | 1 |
| Aldouri, M | 1 |
| Pagliuca, A | 1 |
| Mufti, GJ | 1 |
| Devereux, S | 1 |
| Puig, N | 1 |
| de la Rubia, J | 1 |
| Remigia, MJ | 1 |
| Jarque, I | 1 |
| Martín, G | 1 |
| Cupelli, L | 1 |
| Sanz, GF | 1 |
| Lorenzo, I | 1 |
| Sanz, J | 1 |
| Martínez, JA | 1 |
| Jiménez, C | 1 |
| Sanz, MA | 1 |
| Nickenig, C | 1 |
| Dreyling, M | 1 |
| Hoster, E | 1 |
| Ludwig, WD | 1 |
| Dörken, B | 1 |
| Freund, M | 1 |
| Huber, C | 1 |
| Ganser, A | 1 |
| Trümper, L | 1 |
| Forstpointner, R | 1 |
| Unterhalt, M | 1 |
| Hiddemann, W | 1 |
| Dreger, P | 2 |
| Brand, R | 1 |
| Michallet, M | 1 |
| Müller, MR | 2 |
| Seiler, F | 1 |
| Thomale, J | 2 |
| Buschfort, C | 2 |
| Rajewsky, MF | 2 |
| Seeber, S | 2 |
| von Neuhoff, N | 1 |
| Kuse, R | 1 |
| Sonnen, R | 1 |
| Glass, B | 1 |
| Uharek, L | 1 |
| Schoch, R | 1 |
| Löffler, H | 1 |
| Schmitz, N | 1 |
| Lensing, C | 1 |
| Cull, GM | 1 |
| Haynes, AP | 1 |
| Byrne, JL | 1 |
| Carter, GI | 1 |
| Miflin, G | 1 |
| Rebello, P | 1 |
| Hale, G | 1 |
| Waldmann, H | 1 |
| Russell, NH | 1 |
| Meloni, G | 1 |
| Proia, A | 1 |
| Guerrisi, V | 1 |
| Cordone, I | 1 |
| De Cuia, R | 1 |
| Fenu, S | 1 |
| Mauro, FR | 1 |
| Pescarmona, E | 1 |
| Reato, G | 1 |
| Mandelli, F | 1 |
| Volk, AL | 1 |
| Vannucci, SA | 1 |
| Cook, W | 1 |
| Thompson, KA | 1 |
| Listinsky, CM | 1 |
| Case, DC | 1 |
| Boyd, M | 1 |
| Hayes, DM | 1 |
| Dorsk, BM | 1 |
1 review available for carmustine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Autologous stem cell transplantation for chronic lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Ca | 2007 |
4 trials available for carmustine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Allogeneic stem cell transplantation for relapsed or refractory lymphoma after conditioning with BEAM/fludarabine/TBI.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival | 2013 |
Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamid | 2006 |
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Cyclophospham | 2007 |
Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Cisplatin; Co | 1998 |
7 other studies available for carmustine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Muri | 2006 |
Capacity of individual chronic lymphatic leukemia lymphocytes and leukemic blast cells for repair of O6-ethylguanine in DNA: relation to chemosensitivity in vitro and treatment outcome.
Topics: Acute Disease; Carmustine; Cyclophosphamide; Cytarabine; DNA Repair; Doxorubicin; Drug Resistance; E | 1994 |
DNA repair and cellular resistance to alkylating agents in chronic lymphocytic leukemia.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell | 1997 |
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; | 2000 |
Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantation.
Topics: Acute Disease; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carm | 2000 |
Composite mycosis fungoides and B-cell chronic lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Combined Modality Therapy; | 2002 |
Diffuse well-differentiated lymphocytic lymphoma: chemotherapy with BCNU, cyclophosphamide, vincristine, melphalan and prednisone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Humans; L | 1988 |